Nicolas Isambert
MD, PhD
Medical Oncologist
👥Biography 个人简介
Dr. Nicolas Isambert is a French oncologist specializing in early-phase oncology clinical trials including novel ADC therapeutics. He has been an investigator in trials of tusamitamab ravtansine (SAR408701), an ADC targeting CEACAM5, which is overexpressed in non-squamous NSCLC. His research evaluates CEACAM5 expression as a biomarker and characterizes the efficacy and safety of maytansine-payload ADCs in lung and other solid tumors.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nicolas Isambert 的研究动态
Follow Nicolas Isambert's research updates
留下邮箱，当我们发布与 Nicolas Isambert（Centre Georges-Francois Leclerc）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment